APi Group Q3 2026: Revenue Beats and Full-Year Guidance Raised

As seen on the 24/7 Wall St. homepage on October 29, 2026.

APG APi Group
Q3 2026
EPS
$0.50
est $0.47 +6.3%
Revenue
$2.55B
est $2.40B +6.3%

APi Group raised its full-year revenue outlook to $9.20 to $9.25 billion, from $8.875 to $9.025 billion, on 15.7% organic growth. Management points to a growing backlog into the fourth quarter.

Continue ReadingShow less

APi Group's third-quarter 2026 revenue of $2.55 billion beat expectations, and adjusted diluted EPS of $0.50 also came in above estimates.

Specialty Services carried the quarter, growing revenue 30.7% on disciplined project selection and pricing, with Safety Services adding 18.5% growth.

Sponsored

Adjusted EBITDA margin expanded to 13.7% as lower SG&A outweighed gross margin compression from project mix and higher material and fuel costs.

Management raised full-year 2026 revenue guidance to $9.20 to $9.25 billion. CEO Russ Becker cited a growing backlog and improving margins into the fourth quarter.

Sources

Mentioned: APG

Related Market Updates

HOUSE TRADE DISCLOSURE Gilbert Ray Cisneros, Jr.
  • AMD Advanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO 150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH 150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG 150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP 150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT 150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRC AtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX 150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more